Grapiprant Patent Expiration
About Veterinary Grapiprant
Grapiprant is used in a drug marketed by 1 company: Elanco Us Inc.
Other drugs containing Grapiprant are: Galliprant .
Veterinary Grapiprant Patents
Given below is the list of patents protecting Grapiprant, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| Galliprant | US11369621 | 05 Mar, 2035 | ELANCO US INC. |
| Galliprant | US7960407 | 10 Jul, 2029 | ELANCO US INC. |
| Galliprant | US6710054 | 15 Oct, 2021 | ELANCO US INC. |
Grapiprant Petitions
Details of Grapiprant's suitability petitions are listed below.
| Petitioner | Action | Date of Action | Description |
|---|---|---|---|
 | |||
| Aurora Pharmaceutical, Inc. | Approved | ||
Grapiprant's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List